HTA project overview

Are you interested in what phase a certain HTA project is currently at or do you want to know whether a decision on reimbursement has already been made for a certain HTA project? You will find this information in our project overview table.

HTA Topic Phase Reimbursement decision
Multigene-expression tests for breast cancer Pre-Scoping  
Vitamin B12 tests Completed No change in criteria for reimbursement* (in german)
Medications against dementia in Alzheimer’s and Parkinson's disease  Appraisal/ recommendation In progress
Hormone tests in suspected thyroid dysfunction  Appraisal/ recommendation In progress
Magnesium supplements Pre-Scoping  
Betahistine dihydrochloride and drugs containing cinnarizine in the treatment of Ménière's disease and menière-like syndromes such as dizziness, ringing in the ears, tinnitus and impaired hearing Pre-Scoping  
Palbociclib (Ibrance®), ribociclib (Kisqali®) and abemaciclib (Verzenios®) as a treatment for advanced breast cancer Completed No change in criteria for reimbursement*
Use of the hormone Levothyroxine to treat a slightly underactive thyroid gland Appraisal/ recommendation In progress
Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis Completed No change in criteria for reimbursement*
Sedative and sleep-promoting medicines for the treatment of chronic sleep disorders Appraisal/ recommendation In progress
Surgical widening of the subacromial space for the treatment of lower shoulder pain  Appraisal/ recommendation In progress
Comparison of dosing schedules for drugs to treat bone metastases Appraisal/ recommendation In progress
Statins in the primary prevention of cardiovascular events and mortality in Switzerland Completed Restriction on reimbursement (in german)
The treatment of hypercholesterolaemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines Completed Restriction on reimbursement (in german)
Long-term physiotherapy after a stroke, in multiple sclerosis or Parkinson's disease Appraisal/ recommendation In progress
Vertebroplasty or kyphoplasty in patients with symptomatic osteoporotic vertebral compression fractures Completed Restriction on reimbursement (in german)
Denosumab (Prolia®) for the treatment of osteoporosis Appraisal/ recommendation In progress
Medical cannabis for treating various symptoms in Switzerland Completed No reimbursement (in german)
Corneal collagen crosslinking for the treatment of progressive keratoconus Completed Restriction on reimbursement (in german)
Chondroitin sulfate in osteoarthritis Appraisal/ recommendation In progress
Blood thinner treatment after stent surgery Completed No change in criteria for reimbursement*
Vitamin D Testing Completed Restriction on reimbursement (in german)
Oral anticoagulants for atrial fibrillation HTA report (assessment)  
Point-of-care diagnostic tests Scoping  
Glucocorticosteroids in osteoarthritis Pre-Scoping  
Migraine prophylaxis HTA report (assessment)  
Invasive procedures in coronary artery disease HTA report (assessment)  
Antidepressants for depression Completed No change in criteria for reimbursement*
Therapy duration of Trastuzumab in early-stage HER2-positive breast cancer Pre-Scoping  
Olmesartan mono- and combination therapies in patients with essential hypertension Completed No change in criteria for reimbursement*
Treatment of non-erosive gastroesophageal reflux disease patients with proton pump inhibitors Appraisal/ recommendation In progress
Iron therapy for iron deficiency without anaemia Appraisal/ recommendation In progress
Glinides and glitazones in people with diabetes Completed Restriction on reimbursement (in german)
Blood glucose self-monitoring in people with insulin-untreated type 2 diabetes mellitus  Completed Restriction on reimbursement (in german)
Folate testing HTA report (assessment)  
Knee arthroscopy for the treatment of degenerative changes Appraisal/ recommendation In progress
Removal of osteosynthesis materials (e.g. screws, plates, nails and wires) used to treat bone fractures Completed No change in criteria for reimbursement*
Spinal implants in patients with therapy-resistant pain and/or neurological symptoms Completed Restriction on reimbursement (in german)
Tumor treating fields (TTFields) for patients with  glioblastoma HTA protocol  
CAR-T-cell therapy HTA protocol  
*= Efficacy, appropriateness and cost-effectiveness criteria met

Last modification 03.01.2023

Top of page

Contact

Federal Office of Public Health FOPH
Health insurance benefits Division
Health Technology Assessment Section
Schwarzenburgstrasse 157
3003 Bern
Switzerland
Tel. +41 58 469 17 33
E-mail

Are you interested in receiving regular updates from the Swiss HTA programme? If yes, please subscribe here to our newsletter!

Print contact

https://www.bag.admin.ch/content/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projektuebersicht.html